Artículo Destacado en trastornos del movimiento

Autonomic dysfunction according to disease progression in Parkinson's disease.

Kim JB, Kim BJ, Koh SB, Park KW.

Parkinsonism Relat Disord. 2014 Mar;20(3):303-7. doi: 10.1016/j.parkreldis.2013.12.001.

Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Cui G, Yang X, Wang X, Zhang Z, Yue X, Shi H, Shen X.

Neuropsychiatr Dis Treat. 2014;10:39-46. doi: 10.2147/NDT.S54782.

Spatiotemporal gait parameters for patients with Parkinson's disease compared with normal individuals.

Bovonsunthonchai S, Vachalathiti R, Pisarnpong A, Khobhun F, Hiengkaew V.

Physiother Res Int. 2014 Sep;19(3):158-65. doi: 10.1002/pri.1579.

DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.

Coupland KG, Mellick GD, Silburn PA, Mather K, Armstrong NJ, Sachdev PS, Brodaty H, Huang Y, Halliday GM, Hallupp M, Kim WS, Dobson-Stone C, Kwok JB.

Mov Disord. 2014 Nov;29(13):1606-14. doi: 10.1002/mds.25784. Erratum in: Mov Disord. 2016 May;31(5):768.

Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation.

Greene ID, Mastaglia F, Meloni BP, West KA, Chieng J, Mitchell CJ, Gai WP, Boulos S.

J Neurosci Res. 2014 Apr;92(4):506-16. doi: 10.1002/jnr.23331.

Modeling Parkinson's disease in a dish--a story of yeast and men.

Ebrahimi-Fakhari D, Wahlster L.

Mov Disord. 2014 Jan;29(1):34. doi: 10.1002/mds.25781. No abstract available.

Nizatidine ameliorates gastroparesis in Parkinson's disease: a pilot study.

Doi H, Sakakibara R, Sato M, Hirai S, Masaka T, Kishi M, Tsuyusaki Y, Tateno A, Tateno F, Takahashi O, Ogata T.

Mov Disord. 2014 Apr;29(4):562-6. doi: 10.1002/mds.25777.

Factors predictive of the development of levodopa-induced dyskinesia and Wearing-Off in Parkinson's disease.

Rajput AH.

Mov Disord. 2014 Mar;29(3):429. doi: 10.1002/mds.25800. No abstract available.

Nonmotor symptoms and health-related quality of life in early Parkinson's disease.

Martinez-Martin P.

Mov Disord. 2014 Feb;29(2):166-8. doi: 10.1002/mds.25799. No abstract available.

Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.

Sharp ME, Marder KS, Côté L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN.

Mov Disord. 2014 Apr;29(4):566-8. doi: 10.1002/mds.25792.

Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.

Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE.

Mov Disord. 2014 Apr;29(4):444-50. doi: 10.1002/mds.25789. Review.

A randomized controlled trial of patient-reported outcomes with tai chi exercise in Parkinson's disease.

Li F, Harmer P, Liu Y, Eckstrom E, Fitzgerald K, Stock R, Chou LS.

Mov Disord. 2014 Apr;29(4):539-45. doi: 10.1002/mds.25787.

Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients.

Solla P, Cannas A, Mulas CS, Perra S, Corona A, Bassareo PP, Marrosu F.

J Neurol. 2014 Feb;261(2):382-91. doi: 10.1007/s00415-013-7207-5.

Expression of full-length and truncated trkB in human striatum and substantia nigra neurons: implications for Parkinson's disease.

Fenner ME, Achim CL, Fenner BM.

J Mol Histol. 2014 Jun;45(3):349-61. doi: 10.1007/s10735-013-9562-z.

Principal Component Analysis of gait in Parkinson's disease: relevance of gait velocity.

Dillmann U, Holzhoffer C, Johann Y, Bechtel S, Gräber S, Massing C, Spiegel J, Behnke S, Bürmann J, Louis AK.

Gait Posture. 2014 Mar;39(3):882-7. doi: 10.1016/j.gaitpost.2013.11.021.